Galaxy Medicare Ltd

Galaxy Medicare Ltd

₹ 22.2 -3.26%
16 Dec 3:40 p.m.
About

Incorporated in July 1992, Galaxy Medicare Limited manufactures and exports medical devices, POP bandages, and surgical dressings in India.[1]

Key Points

Business Profile[1]
Galaxy manufactures, trades, and exports medical devices with a focus on POP bandages, medical tapes, surgical dressings, and wound care products. It operates through its own brands, OEM supply, government/institutional sales, exports, and trading channels.

  • Market Cap 33.8 Cr.
  • Current Price 22.2
  • High / Low 54.0 / 18.1
  • Stock P/E 9.17
  • Book Value 26.0
  • Dividend Yield 1.57 %
  • ROCE 17.7 %
  • ROE 14.5 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Stock is trading at 0.86 times its book value
  • Debtor days have improved from 82.0 to 64.7 days.

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Sep 2024 Mar 2025 Sep 2025
17.24 21.96 18.73
14.74 19.81 15.87
Operating Profit 2.50 2.15 2.86
OPM % 14.50% 9.79% 15.27%
0.55 0.52 0.33
Interest 0.38 0.31 0.11
Depreciation 0.25 0.25 0.30
Profit before tax 2.42 2.11 2.78
Tax % 29.34% 21.80% 27.34%
1.71 1.66 2.02
EPS in Rs 1.44 1.40 1.33
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2021 Mar 2023 Mar 2024 Mar 2025 TTM
28.57 30.94 35.84 38.86 40.69
26.41 28.59 30.87 34.16 35.68
Operating Profit 2.16 2.35 4.97 4.70 5.01
OPM % 7.56% 7.60% 13.87% 12.09% 12.31%
0.50 1.72 1.18 1.07 0.85
Interest 0.80 0.95 0.94 0.74 0.42
Depreciation 0.82 1.12 0.48 0.50 0.55
Profit before tax 1.04 2.00 4.73 4.53 4.89
Tax % 30.77% 21.50% 21.56% 25.61%
0.72 1.57 3.71 3.37 3.68
EPS in Rs 2.57 5.16 3.13 2.84 2.73
Dividend Payout % 9.72% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 8%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -2%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 14%

Balance Sheet

Figures in Rs. Crores

Mar 2021 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 2.80 3.04 11.86 11.86 15.17
Reserves 12.88 14.78 9.51 12.29 24.30
8.78 9.15 8.12 4.61 2.52
5.44 5.34 3.05 2.73 3.44
Total Liabilities 29.90 32.31 32.54 31.49 45.43
13.95 14.57 14.41 14.13 14.03
CWIP 0.20 0.06 0.00 0.00 0.00
Investments 2.98 2.69 3.11 2.82 3.04
12.77 14.99 15.02 14.54 28.36
Total Assets 29.90 32.31 32.54 31.49 45.43

Cash Flows

Figures in Rs. Crores

Mar 2021 Mar 2023 Mar 2024 Mar 2025
5.56 3.65 2.71 4.49
-4.46 -1.91 -0.65 0.32
-1.11 -1.80 -2.08 -4.72
Net Cash Flow 0.00 -0.07 -0.03 0.09

Ratios

Figures in Rs. Crores

Mar 2021 Mar 2023 Mar 2024 Mar 2025
Debtor Days 93.26 106.65 74.65 64.72
Inventory Days 73.90 101.37 123.74 84.75
Days Payable 101.66 91.77 32.29 22.05
Cash Conversion Cycle 65.50 116.24 166.10 127.42
Working Capital Days 0.51 36.10 56.93 68.94
ROCE % 18.53% 17.72%

Shareholding Pattern

Numbers in percentages

7 Recently
Sep 2025
72.43%
1.85%
25.73%
No. of Shareholders 856

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents